Shandong Dongyue Organosilicon Materials Past Earnings Performance
Past criteria checks 0/6
Shandong Dongyue Organosilicon Materials's earnings have been declining at an average annual rate of -17.8%, while the Chemicals industry saw earnings growing at 8.4% annually. Revenues have been growing at an average rate of 18.9% per year.
Key information
-17.8%
Earnings growth rate
-22.9%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | 18.9% |
| Return on equity | -3.2% |
| Net Margin | -3.2% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Shandong Dongyue Organosilicon Materials makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 4,823 | -156 | 74 | 205 |
| 31 Dec 23 | 4,801 | -271 | 73 | 234 |
| 30 Sep 23 | 5,163 | -354 | 84 | 278 |
| 30 Jun 23 | 5,715 | -199 | 81 | 302 |
| 31 Mar 23 | 6,789 | 200 | 85 | 316 |
| 01 Jan 23 | 6,734 | 511 | 88 | 317 |
| 30 Sep 22 | 6,645 | 952 | 41 | 301 |
| 30 Jun 22 | 6,182 | 1,299 | 64 | 292 |
| 31 Mar 22 | 4,966 | 1,269 | 71 | 263 |
| 31 Dec 21 | 4,333 | 1,151 | 79 | 232 |
| 30 Sep 21 | 3,600 | 946 | 127 | 226 |
| 30 Jun 21 | 3,002 | 567 | 119 | 222 |
| 31 Mar 21 | 2,638 | 349 | 118 | 212 |
| 31 Dec 20 | 2,503 | 281 | 114 | 186 |
| 30 Sep 20 | 2,372 | 207 | 93 | 159 |
| 30 Jun 20 | 2,499 | 324 | 118 | 118 |
| 31 Mar 20 | 2,626 | 525 | 123 | 93 |
| 31 Dec 19 | 2,733 | 553 | 121 | 86 |
| 30 Sep 19 | 2,938 | 567 | 193 | 65 |
| 30 Jun 19 | 3,001 | 528 | 217 | 63 |
| 31 Mar 19 | 3,194 | 523 | 213 | 50 |
| 31 Dec 18 | 3,401 | 663 | 216 | 45 |
| 31 Dec 17 | 2,441 | 310 | 100 | 3 |
| 31 Dec 16 | 1,692 | 61 | 93 | 2 |
| 31 Dec 15 | 1,454 | -35 | 77 | 2 |
Quality Earnings: 300821 is currently unprofitable.
Growing Profit Margin: 300821 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300821 is unprofitable, and losses have increased over the past 5 years at a rate of 17.8% per year.
Accelerating Growth: Unable to compare 300821's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 300821 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-21.2%).
Return on Equity
High ROE: 300821 has a negative Return on Equity (-3.17%), as it is currently unprofitable.